Two rhenium(I) tricarbonyl complexes with the tridentate monoanionic NSO ligands, 4-(benzimidazol-2-yl)-3-thiabutanoic acid (complex 3) and [1-(11-carboxyundecanyl)-4-(benzimidazol-2-yl)]-3-thiabutanoic acid (complex 4) were synthesized and characterized by spectroscopic methods and elemental analysis. X-ray crystallographic analysis of complex 3 revealed a distorted octahedral geometry around rhenium defined by the three facially bound CO groups and the NSO donor atom set of the tridentate ligand. The analogous technetium-99m complexes (complexes 5 and 6) were also prepared quantitatively by reaction of the NSO ligands with the fac-[Tc-99m(H2O)(3)(CO)(3)](+) synthon and their identity was established by chromatographic comparison to their ...
The aim of this research is to develop new rhenium complexes with favorable bio-distribution propert...
With the aim of preparing hypoxia-selective imaging and therapeutic agents, technetium(I) and rheni...
With the aim of preparing hypoxia-selective imaging and therapeutic agents, technetium(I) and rheni...
Two rhenium(I) tricarbonyl complexes with the tridentate monoanionic NSO ligands, 4-(benzimidazol-2-...
Two rhenium(l) tricarbonyl complexes, with the monoanionic tridentate NSO type ligand, 4-(imidazolin...
Two rhenium(l) tricarbonyl complexes, with the monoanionic tridentate NSO type ligand, 4-(imidazolin...
The synthesis and characterization of the new NSN tridentate bifunctional chelating agent 3-[2-(2'-p...
We have explored the coordination chemistry of rhenium in the attempt to develop radiopharmaceutical...
A general synthetic approach to a novel range of semirigid bifunctional chelating agents (BCAs) that...
A number of rhenium compounds were synthesized and characterized in an attempt to investigate and ex...
A strategy for the conjugation of N-heterocyclic carbene (NHC) ligands to biomolecules via amide bon...
International audienceA general synthetic approach to a novel range of semirigid bifunctional chelat...
International audienceA general synthetic approach to a novel range of semirigid bifunctional chelat...
International audienceA general synthetic approach to a novel range of semirigid bifunctional chelat...
International audienceA general synthetic approach to a novel range of semirigid bifunctional chelat...
The aim of this research is to develop new rhenium complexes with favorable bio-distribution propert...
With the aim of preparing hypoxia-selective imaging and therapeutic agents, technetium(I) and rheni...
With the aim of preparing hypoxia-selective imaging and therapeutic agents, technetium(I) and rheni...
Two rhenium(I) tricarbonyl complexes with the tridentate monoanionic NSO ligands, 4-(benzimidazol-2-...
Two rhenium(l) tricarbonyl complexes, with the monoanionic tridentate NSO type ligand, 4-(imidazolin...
Two rhenium(l) tricarbonyl complexes, with the monoanionic tridentate NSO type ligand, 4-(imidazolin...
The synthesis and characterization of the new NSN tridentate bifunctional chelating agent 3-[2-(2'-p...
We have explored the coordination chemistry of rhenium in the attempt to develop radiopharmaceutical...
A general synthetic approach to a novel range of semirigid bifunctional chelating agents (BCAs) that...
A number of rhenium compounds were synthesized and characterized in an attempt to investigate and ex...
A strategy for the conjugation of N-heterocyclic carbene (NHC) ligands to biomolecules via amide bon...
International audienceA general synthetic approach to a novel range of semirigid bifunctional chelat...
International audienceA general synthetic approach to a novel range of semirigid bifunctional chelat...
International audienceA general synthetic approach to a novel range of semirigid bifunctional chelat...
International audienceA general synthetic approach to a novel range of semirigid bifunctional chelat...
The aim of this research is to develop new rhenium complexes with favorable bio-distribution propert...
With the aim of preparing hypoxia-selective imaging and therapeutic agents, technetium(I) and rheni...
With the aim of preparing hypoxia-selective imaging and therapeutic agents, technetium(I) and rheni...